Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

303.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 65,572
  • Market Cap: £321.71m
  • RiskGrade: 125
  • Beta: 0.02

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
76.58% above the market average76.58% above the market average76.58% above the market average76.58% above the market average76.58% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.79% above the market average4.79% above the market average4.79% above the market average4.79% above the market average4.79% above the market average
18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average
Price Book Ratio
83.19% below the market average83.19% below the market average83.19% below the market average83.19% below the market average83.19% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
53.87% below the market average53.87% below the market average53.87% below the market average53.87% below the market average53.87% below the market average
44.68% below the sector average44.68% below the sector average44.68% below the sector average44.68% below the sector average44.68% below the sector average
Price Chg 3m
53.22% below the market average53.22% below the market average53.22% below the market average53.22% below the market average53.22% below the market average
27.66% below the sector average27.66% below the sector average27.66% below the sector average27.66% below the sector average27.66% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.93% below the market average39.93% below the market average39.93% below the market average39.93% below the market average39.93% below the market average
39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average
Momentum 20
18.84% above the market average18.84% above the market average18.84% above the market average18.84% above the market average18.84% above the market average
44.19% above the sector average44.19% above the sector average44.19% above the sector average44.19% above the sector average44.19% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
63.65% below the market average63.65% below the market average63.65% below the market average63.65% below the market average63.65% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
96.01% below the market average96.01% below the market average96.01% below the market average96.01% below the market average96.01% below the market average
95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
28.30% above the market average28.30% above the market average28.30% above the market average28.30% above the market average28.30% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average
Operating Profit Loss
94.71% below the market average94.71% below the market average94.71% below the market average94.71% below the market average94.71% below the market average
91.49% below the sector average91.49% below the sector average91.49% below the sector average91.49% below the sector average91.49% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
46.62% above the market average46.62% above the market average46.62% above the market average46.62% above the market average46.62% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Cash
57.83% above the market average57.83% above the market average57.83% above the market average57.83% above the market average57.83% above the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
53.9% below the market average53.9% below the market average53.9% below the market average53.9% below the market average53.9% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Brokers Percent Neutral
38.79% above the market average38.79% above the market average38.79% above the market average38.79% above the market average38.79% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 303.50p
Change Today -1.00p
% Change -0.33 %
52 Week High 445.00
52 Week Low 232.50
Volume 65,572
Shares Issued 106.00m
Market Cap £321.71m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.45% below the market average30.45% below the market average30.45% below the market average30.45% below the market average30.45% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average
Price Trend
50.97% below the market average50.97% below the market average50.97% below the market average50.97% below the market average50.97% below the market average
6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average
Income Not Available
Growth
1.80% above the market average1.80% above the market average1.80% above the market average1.80% above the market average1.80% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 22-May-2025

Time Volume / Share Price
16:35 19,685 @ 303.50p
16:35 216 @ 303.50p
16:35 253 @ 303.50p
16:35 50 @ 303.50p
16:35 36 @ 303.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page